Joost Bart

6.5k total citations · 2 hit papers
81 papers, 4.9k citations indexed

About

Joost Bart is a scholar working on Oncology, Reproductive Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joost Bart has authored 81 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 20 papers in Reproductive Medicine and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joost Bart's work include Ovarian cancer diagnosis and treatment (18 papers), Drug Transport and Resistance Mechanisms (13 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Joost Bart is often cited by papers focused on Ovarian cancer diagnosis and treatment (18 papers), Drug Transport and Resistance Mechanisms (13 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Joost Bart collaborates with scholars based in Netherlands, United States and Germany. Joost Bart's co-authors include N. Harry Hendrikse, Willem Vaalburg, Gooitzen M. van Dam, Rick G. Pleijhuis, Elisabeth G.E. de Vries, Johannes S. de Jong, Lucia M.A. Crane, Antoon T. M. Willemsen, George Themelis and Athanasios Sarantopoulos and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Joost Bart

76 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

2011 1.3k citations Gooitzen M. van Dam, Rick G. Pleijhuis et al. profile →
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo

2005 567 citations Willem Vaalburg, Joost Bart et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joost Bart Netherlands	29	1.7k	1.1k	1.1k	982	760	81	4.9k
François Paris France	36	1.2k 0.7×	3.1k 2.7×	1.5k 1.4×	449 0.5×	989 1.3×	90	6.3k
Nicholas van Bruggen United States	28	787 0.5×	2.5k 2.2×	1.3k 1.2×	943 1.0×	656 0.9×	46	6.4k
Yasuhisa Fujibayashi Japan	46	1.1k 0.6×	1.5k 1.3×	3.7k 3.5×	645 0.7×	1.5k 2.0×	237	7.3k
H. Ian Robins United States	41	1.4k 0.8×	1.6k 1.4×	645 0.6×	899 0.9×	958 1.3×	196	5.8k
Joel M. Reid United States	51	3.0k 1.7×	4.5k 3.9×	961 0.9×	548 0.6×	958 1.3×	270	10.0k
Kristin Waite United States	38	1.4k 0.8×	3.9k 3.4×	1.1k 1.0×	657 0.7×	1.7k 2.2×	103	10.0k
Xiaobu Ye United States	39	2.6k 1.5×	1.3k 1.1×	771 0.7×	627 0.6×	889 1.2×	151	6.8k
Steven Brem United States	45	1.5k 0.8×	2.9k 2.5×	1.3k 1.2×	716 0.7×	1.6k 2.1×	193	7.7k
Do‐Hyun Nam South Korea	44	1.3k 0.7×	1.6k 1.4×	765 0.7×	560 0.6×	842 1.1×	239	6.7k
Yicheng Ni Belgium	44	1.2k 0.7×	1.4k 1.2×	2.3k 2.1×	1.3k 1.3×	588 0.8×	279	7.1k

Countries citing papers authored by Joost Bart

Since Specialization

Citations

This map shows the geographic impact of Joost Bart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost Bart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost Bart more than expected).

Fields of papers citing papers by Joost Bart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joost Bart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost Bart. The network helps show where Joost Bart may publish in the future.

Co-authorship network of co-authors of Joost Bart

This figure shows the co-authorship network connecting the top 25 collaborators of Joost Bart. A scholar is included among the top collaborators of Joost Bart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joost Bart. Joost Bart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vledder, Annegé, Nienke van Rooij, Annechien Plat, et al.. (2025). Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial. Clinical Cancer Research. 31(6). 1016–1026. 4 indexed citations

Requesens, Marta, Nienke van Rooij, Hagma H. Workel, et al.. (2025). Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level. Cancer Immunology Research. 13(12). 1911–1924.

Nijsten, Maarten W., et al.. (2024). Delayed Diagnosis of Disseminated Invasive Aspergillosis with Purulent Myocarditis in an Immunocompromised Host. Infectious Disease Reports. 16(6). 1182–1190.

Dasgupta, Shatavisha, Patricia C. Ewing‐Graham, Joost Bart, et al.. (2024). Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy. Gynecologic Oncology. 187. 113–119. 6 indexed citations

Bleeker, Maaike C.G., Tjalling Bosse, Koen Van de Vijver, et al.. (2024). Does “One Size Fits All”? Rethinking FIGO Depth of Invasion Measurements in Vulvar Cancer. International Journal of Gynecological Pathology. 43(5). 457–463.

Visser, Annie, Jolien F. van Nimwegen, S.C. Liefers, et al.. (2024). Increased Interferon Signaling in Vaginal Tissue of Patients With Primary Sjögren Syndrome. The Journal of Rheumatology. 51(7). 687–695. 2 indexed citations

Bart, Joost, Marian J.E. Mourits, Stefan M. Willems, et al.. (2024). BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study. Cancers. 16(9). 1682–1682. 2 indexed citations

Kroon, Cor D. de, et al.. (2023). Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands. Cancer Epidemiology. 85. 102405–102405. 2 indexed citations

Mourits, Marian J.E., et al.. (2023). BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients. International Journal of Gynecological Cancer. 33(8). 1260–1269. 1 indexed citations

10.

Yigit, Refika, et al.. (2023). The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter. Journal of Gynecologic Oncology. 34(6). e75–e75. 2 indexed citations

11.

Maaren, Marissa C. van, Jeannette G. van Manen, Marian B. E. Menke‐Pluijmers, et al.. (2021). Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis. The Breast. 59. 376–382. 10 indexed citations

12.

Koopman, Timco, Bert van der Vegt, Marcel Dijkstra, et al.. (2018). HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and within‐situhybridisation. Histopathology. 73(5). 852–863. 28 indexed citations

13.

Dekker, Tim, Gerrit K. Hooijer, Sybren L. Meijer, et al.. (2015). Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach. Breast Cancer Research and Treatment. 152(2). 247–252. 16 indexed citations

14.

Boers, James E., et al.. (2011). High Concordance of 5 HER2 In Situ Hybridization Methods with Abbott FISH.. Laboratory Investigation. 71. 1 indexed citations

15.

Vermeij, Renee, Ninke Leffers, Baukje‐Nynke Hoogeboom, et al.. (2011). Potentiation of a p53‐SLP vaccine by cyclophosphamide in ovarian cancer: A single‐arm phase II study. International Journal of Cancer. 131(5). E670–80. 72 indexed citations

16.

Vijver, Marc J. van de, Pieter Wesseling, Jelle Wesseling, et al.. (2010). Receptor conversion in distant breast cancer metastases. Breast Cancer Research. 12(5). R75–R75. 180 indexed citations

17.

Hollema, H., et al.. (2009). P-gp and MRP1 Expression in Parathyroid Tumors Related to Histology, Weight and ^99 mTc-Sestamibi Imaging Results. Experimental and Clinical Endocrinology & Diabetes. 117(8). 406–412. 8 indexed citations

18.

Dijkers, Eli, Jos G. W. Kosterink, Lars R. Perk, et al.. (2009). Development and Characterization of Clinical-Grade ⁸⁹Zr-Trastuzumab for HER2/neu ImmunoPET Imaging. Journal of Nuclear Medicine. 50(6). 974–981. 271 indexed citations

19.

Pleijhuis, Rick G., Maurits Graafland, Jakob de Vries, et al.. (2009). Obtaining Adequate Surgical Margins in Breast-Conserving Therapy for Patients with Early-Stage Breast Cancer: Current Modalities and Future Directions. Annals of Surgical Oncology. 16(10). 2717–2730. 255 indexed citations

20.

Bart, Joost, et al.. (2000). The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treatment Reviews. 26(6). 449–462. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact